G20/Neuroscience 20 (N20) World Brain Mapping & Therapeutics Initiative


G20 World Brain Mapping & Therapeutics Initiative on Wikipedia

The G20 World Brain Mapping & Therapeutic Scientific Summit aims to contribute to President Obama's BRAIN initiative and to expand action on the current and upcoming initiatives across the G20 nations, bringing the finest scientists, engineers, physicians and surgeons across the globe in order to rapidly introduce clinical solutions for neurological disorders, which cost the world economy hundreds of billions of dollars annually. G20 World Brain Mapping Summit was launched in 2014 on the initiative of The Society for Brain Mapping and Therapeutics (SBMT).  Read more...  

G20 Summit /Neuroscience 20
(Brain 20, Mental Health 20 and Spine 20)
Supporting Papers

2019 Japan amendment to the 2018 Resolution

2019 Japan amendment to the 2018 Resolution
Read more...  

2018 Argentina Resolution

2018 Argentina Resolution
Read more...  

A proposed G20 priority due to Major Impact of the Cost of Neurological Disorders on the World Economy by Dr. Kuldip Sidhu and Dr. Babak Kateb

A proposed G20 priority due to Major Impact of the Cost of Neurological Disorders on the World Economy by Dr. Kuldip Sidhu and Dr. Babak Kateb. According to a World Health Organization large-scale study, about a third of the adult worldwide population suffer from a mental disorder such as depression, anxiety and schizophrenia.
Read more...  

Nature Biotechnology -href=

Nature Biotechnology - 6/2013
$350 Million in New Funding for US BRAIN Initiative announced by President Obama. The principal goal of the BRAIN Initiative is to help researchers find new ways to treat, cure or prevent brain disorders, such as Alzheimer's disease, epilepsy and traumatic brain injury.
Read more...  

Congressman Earl Blumenauer (D-OR)

Hon. Kirsty Duncan, MP of Canada

Hon Mal Brough MP – Parliament of Australia

Congressman Andy Harris (R-MD 1st District)

SBS World report about N20 BRAIN Initiative

Saudi Arabia - 2020
  • 2020

Saudi Arabia

City: Riyadh
November 21-22, 2020

Summit Chair:
Dr. Babak Kateb

Summit Vice Chair:
Dr. Robert Hariri

Dr. Saleem I. Abdulrauf

Registration

Read More  

Japan- 2019
  • 2019

Osaka Japan

June 27-28, 2019

Summit Chair: Dr. Babak Kateb

Summit Vice Chair:

Dr. Shigeo Okabe

Dr. Hiroaki Nakamura

Germany - 2017
  • 2018

Argentina

City: Puerto Madero
November 26-27, 2018

Summit Chair:
Dr. Babak Kateb

Summit Vice Chair:
Dr. Alejandro Mercado
Dr. Venkatraman Sadanand

  Download
Program - Talks 

  Download
Program - Panel
Discussions 

Press
Release  

Germany - 2017
  • 2017

Germany

City: Hamburg
July 5, 2017

Summit Chair:
Dr. Babak Kateb

Summit Vice Chair:
Dr. Carsten Claussen

Read More

Press
Release  

China - 2016
  • 2016

China

City: Hangzhou
September 4, 2016

Summit Chair:
Dr. Babak Kateb

Summit Vice Chair:
Dr. Dong Zhou

Turkey - 2015
  • 2015

Turkey

City: Antalya
November 13-15, 2015

Summit Chair:
Dr. Babak Kateb

Summit Vice Chair:
Dr. Nevzat Tarhan

Read More  

Australia - 2014
  • 2014

Australia

City: Brisbane
November 13, 2014

Summit Chair:
Dr. Babak Kateb

Summit Vice Chair:
Dr. Kuldip Sidhu

Press
Release  

Goals of Neuroscience-20, N20
(Brain20, Spine20 and Mental Health20)

  1. Build a global alliance for brain, spine and mental health/illness.
  2. 2N20 encourages a consortium approach to research and development.
  3. N20 advocates for a global harmonization of the related policies/standardization of data.
  4. N20 encourages a neuro-economical assessment of the future impact of disease, diagnostics and prevention.
  5. N20 encourages facilitating translation and commercialization of technologies across disciplines of science to rapidly identify and introduce new generation of therapeutics including stem cells, nanotechnology, device, and imaging (a nanobioelectronic consortium/ company spinoffs).
  6. N20 advocates for unifying global regulations and guidelines on clinical trials and drug/device - combination discovery.
  7. N20 advocates for advancing innovation in brain, spine, and mental health through a global partnership and new funding initiatives between academic centers, industry, non-profit organizations, and government agencies.
  8. N20 is a critical brain and spine consortium to facilitate integration of nanotechnology, artificial intelligence, virtual reality/augmented reality, supercomputing, multimodality brain mapping/imaging (MEG), cellular therapeutics, neurophotonics and/or devices which could address the fast tracking innovation, reduce the cost of the healthcare delivery and make it more efficient.
  9. N20 will be bringing the global brain and spine initiatives together to identify best clinical and basic science practices and create a united front to push for new effective therapeutics.
  10. Set unified standard amongst all, for training, prevention, care, and advance therapeutics related to brain, spine and mental disorders including physicians, engineers, surgeons, nurses, chiropractors, physical therapists, osteopaths, physiologists, and other related disciplines.
  11. Provide capabilities at the local, regional, and national levels to advance practice of clinical neuroscience (brain, spine and mental health/illness) through advocacy by engaging health ministries and government programs across the globe.
  12. Advocate for a global research and innovation funding for brain, spine and mental health.
  13. Facilitating investment and commercialization of neuro-technologies for brain, spine and mental health/illness.
  14. Educate professionals, patients and families about the latest state of science, technology, innovation and policies in clinical neuroscience (brain, spine and mental health/illness).
  15. Provide accurate and up to date resources and data to the governments of G20 nation and beyond to adapt new policies for clinical neuroscience.
  16. Spread awareness amongst all to address mental/psychological issues such as PTSD for healthcare workers, anxiety and stress for patients, for those who lost jobs and about prospect of future after the pandemic and prevention of suicides in the present and post-COVID-19 era.